{
  "guideline": {
    "id": "PA166119846",
    "name": "Annotation of CPIC Guideline for dapsone, methylene blue, pegloticase, rasburicase, tafenoquine, toluidine blue and G6PD",
    "source": "CPIC",
    "version": 45,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166119846",
    "relatedChemicals": [
      {
        "id": "PA449211",
        "name": "dapsone",
        "symbol": null
      },
      {
        "id": "PA450457",
        "name": "methylene blue",
        "symbol": null
      },
      {
        "id": "PA165963961",
        "name": "pegloticase",
        "symbol": null
      },
      {
        "id": "PA10176",
        "name": "rasburicase",
        "symbol": null
      },
      {
        "id": "PA166115580",
        "name": "tafenoquine",
        "symbol": null
      },
      {
        "id": "PA166268821",
        "name": "toluidine blue",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA28469",
        "name": "glucose-6-phosphate dehydrogenase",
        "symbol": "G6PD"
      }
    ],
    "recommendation": true
  },
  "recommendations": [
    {
      "id": "PA166298576",
      "name": "Recommendation PA166298576",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA166268821",
          "name": "toluidine blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061178,
        "html": "<p>No reason to avoid based on G6PD status</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Toluidine blue classification strength is based on extrapolation from methylene blue data</p>\n"
      },
      "implications": [
        "G6PD: Low risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Normal"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297619",
      "name": "Recommendation PA166297619",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA10176",
          "name": "rasburicase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060221,
        "html": "<p>No reason to avoid based on G6PD status</p>\n"
      },
      "implications": [
        "G6PD: Low risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Normal"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297579",
      "name": "Recommendation PA166297579",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA449211",
          "name": "dapsone",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060181,
        "html": "<p>Avoid use</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Deficient"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166298519",
      "name": "Recommendation PA166298519",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA166115580",
          "name": "tafenoquine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061121,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n"
      },
      "implications": [
        "G6PD: Unknown risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Indeterminate"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166297611",
      "name": "Recommendation PA166297611",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA449211",
          "name": "dapsone",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060213,
        "html": "<p>No reason to avoid based on G6PD status</p>\n"
      },
      "implications": [
        "G6PD: Low risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Normal"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297615",
      "name": "Recommendation PA166297615",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA165963961",
          "name": "pegloticase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060217,
        "html": "<p>Avoid use</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Deficient"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166298241",
      "name": "Recommendation PA166298241",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA450457",
          "name": "methylene blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060843,
        "html": "<p>Avoid use</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Although there are not published data in individuals with the G6PD Deficient with CNSHA phenotype, there is a strong rationale to avoid these drugs based on evidence in G6PD Deficient individuals.</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute exacerbation of chronic hemolysis"
      ],
      "lookupKey": {
        "G6PD": "Deficient with CNSHA"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297620",
      "name": "Recommendation PA166297620",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA10176",
          "name": "rasburicase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060222,
        "html": "<p>Avoid use</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Deficient"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297580",
      "name": "Recommendation PA166297580",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA449211",
          "name": "dapsone",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060182,
        "html": "<p>Avoid use</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Although there are not published data in individuals with the G6PD Deficient with CNSHA phenotype, there is a strong rationale to avoid these drugs based on evidence in G6PD Deficient individuals.</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute eacerbation of chronic hemolysis"
      ],
      "lookupKey": {
        "G6PD": "Deficient with CNSHA"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166298242",
      "name": "Recommendation PA166298242",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA450457",
          "name": "methylene blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060844,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Due to X-linked mosaicism, individuals with more than one X chromosome (e.g., females, individuals with Klinefelter syndrome) and heterozygous for one non-deficient (class IV) and one deficient (class I–III) allele may display a normal or a deficient phenotype; an enzyme activity test is needed to assign G6PD phenotype in such cases.</p>\n"
      },
      "implications": [
        "G6PD: Variable risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Variable"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166298515",
      "name": "Recommendation PA166298515",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA166115580",
          "name": "tafenoquine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061117,
        "html": "<p>No reason to avoid based on G6PD status</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Tafenoquine’s safety has been established for a G6PD enzyme activity ≥70% of normal. (Inclusion criteria for clinical trials involving tafenoquine included G6PD activity ≥70%.)</p>\n"
      },
      "implications": [
        "G6PD: Low risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Normal"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297612",
      "name": "Recommendation PA166297612",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA449211",
          "name": "dapsone",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060214,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Due to X-linked mosaicism, individuals with more than one X chromosome (e.g., females, individuals with Klinefelter syndrome) and heterozygous for one non-deficient (class IV) and one deficient (class I–III) allele may display a normal or a deficient phenotype; an enzyme activity test is needed to assign G6PD phenotype in such cases.</p>\n"
      },
      "implications": [
        "G6PD: Variable risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Variable"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166297616",
      "name": "Recommendation PA166297616",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA165963961",
          "name": "pegloticase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060218,
        "html": "<p>Avoid use</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Although there are not published data in individuals with the G6PD Deficient with CNSHA phenotype, there is a strong rationale to avoid these drugs based on evidence in G6PD Deficient individuals.</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute eacerbation of chronic hemolysis"
      ],
      "lookupKey": {
        "G6PD": "Deficient with CNSHA"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166298239",
      "name": "Recommendation PA166298239",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA450457",
          "name": "methylene blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060841,
        "html": "<p>No reason to avoid based on G6PD status</p>\n"
      },
      "implications": [
        "G6PD: Low risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Normal"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166298569",
      "name": "Recommendation PA166298569",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA166268821",
          "name": "toluidine blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061171,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Due to X-linked mosaicism, individuals with more than one X chromosome (e.g., females, individuals with Klinefelter syndrome) and heterozygous for one non-deficient (class IV) and one deficient (class I–III) allele may display a normal or a deficient phenotype; an enzyme activity test is needed to assign G6PD phenotype in such cases. Toluidine blue classification strength is based on extrapolation from methylene blue data</p>\n"
      },
      "implications": [
        "G6PD: Variable risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Variable"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166297621",
      "name": "Recommendation PA166297621",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA10176",
          "name": "rasburicase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060223,
        "html": "<p>Avoid use</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Although there are not published data in individuals with the G6PD Deficient with CNSHA phenotype, there is a strong rationale to avoid these drugs based on evidence in G6PD Deficient individuals.</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute eacerbation of chronic hemolysis"
      ],
      "lookupKey": {
        "G6PD": "Deficient with CNSHA"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166298543",
      "name": "Recommendation PA166298543",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA166268821",
          "name": "toluidine blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061145,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Toluidine blue classification strength is based on extrapolation from methylene blue data</p>\n"
      },
      "implications": [
        "G6PD: Unknown risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Indeterminate"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166297613",
      "name": "Recommendation PA166297613",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA449211",
          "name": "dapsone",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060215,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n"
      },
      "implications": [
        "G6PD: Unknown risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Indeterminate"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166298243",
      "name": "Recommendation PA166298243",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA450457",
          "name": "methylene blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060845,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n"
      },
      "implications": [
        "G6PD: Unknown risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Indeterminate"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166297622",
      "name": "Recommendation PA166297622",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA10176",
          "name": "rasburicase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060224,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Due to X-linked mosaicism, individuals with more than one X chromosome (e.g., females, individuals with Klinefelter syndrome) and heterozygous for one non-deficient (class IV) and one deficient (class I–III) allele may display a normal or a deficient phenotype; an enzyme activity test is needed to assign G6PD phenotype in such cases.</p>\n"
      },
      "implications": [
        "G6PD: Variable risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Variable"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166298516",
      "name": "Recommendation PA166298516",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA166115580",
          "name": "tafenoquine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061118,
        "html": "<p>Avoid use</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Deficient"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297617",
      "name": "Recommendation PA166297617",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA165963961",
          "name": "pegloticase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060219,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Due to X-linked mosaicism, individuals with more than one X chromosome (e.g., females, individuals with Klinefelter syndrome) and heterozygous for one non-deficient (class IV) and one deficient (class I–III) allele may display a normal or a deficient phenotype; an enzyme activity test is needed to assign G6PD phenotype in such cases.</p>\n"
      },
      "implications": [
        "G6PD: Variable risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Variable"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166298534",
      "name": "Recommendation PA166298534",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA166268821",
          "name": "toluidine blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061136,
        "html": "<p>Avoid use</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Although there are not published data in individuals with the G6PD Deficient with CNSHA phenotype, there is a strong rationale to avoid these drugs based on evidence in G6PD Deficient individuals. Toluidine blue classification strength is based on extrapolation from methylene blue data</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute exacerbation of chronic hemolysis"
      ],
      "lookupKey": {
        "G6PD": "Deficient with CNSHA"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166298518",
      "name": "Recommendation PA166298518",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA166115580",
          "name": "tafenoquine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061120,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Due to X-linked mosaicism, individuals with more than one X chromosome (e.g., females, individuals with Klinefelter syndrome) and heterozygous for one non-deficient (class IV) and one deficient (class I–III) allele may display a normal or a deficient phenotype; an enzyme activity test is needed to assign G6PD phenotype in such cases. Tafenoquine’s safety has been established for a G6PD enzyme activity ≥70% of normal. (Inclusion criteria for clinical trials involving tafenoquine included G6PD activity ≥70%.)</p>\n"
      },
      "implications": [
        "G6PD: Variable risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Variable"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166298509",
      "name": "Recommendation PA166298509",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA166268821",
          "name": "toluidine blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061111,
        "html": "<p>Avoid use</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Toluidine blue classification strength is based on extrapolation from methylene blue data</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Deficient"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297614",
      "name": "Recommendation PA166297614",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA165963961",
          "name": "pegloticase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060216,
        "html": "<p>No reason to avoid based on G6PD status</p>\n"
      },
      "implications": [
        "G6PD: Low risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Normal"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297623",
      "name": "Recommendation PA166297623",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA10176",
          "name": "rasburicase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060225,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n"
      },
      "implications": [
        "G6PD: Unknown risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Indeterminate"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166298517",
      "name": "Recommendation PA166298517",
      "population": "general",
      "classification": {
        "term": "Strong",
        "termId": "guidelineStrength:981501930"
      },
      "relatedChemicals": [
        {
          "id": "PA166115580",
          "name": "tafenoquine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061119,
        "html": "<p>Avoid use</p>\n<h4 id=\"other-considerations\">Other Considerations</h4>\n<p>Although there are not published data in individuals with the G6PD Deficient with CNSHA phenotype, there is a strong rationale to avoid these drugs based on evidence in G6PD Deficient individuals.</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute exacerbation of chronic hemolysis"
      ],
      "lookupKey": {
        "G6PD": "Deficient with CNSHA"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166297618",
      "name": "Recommendation PA166297618",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA165963961",
          "name": "pegloticase",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060220,
        "html": "<p>To ascertain G6PD status, enzyme activity must be measured. Drug use should be guided per the recommendations based on the activity-based phenotype.</p>\n"
      },
      "implications": [
        "G6PD: Unknown risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Indeterminate"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166298240",
      "name": "Recommendation PA166298240",
      "population": "general",
      "classification": {
        "term": "Moderate",
        "termId": "guidelineStrength:981501931"
      },
      "relatedChemicals": [
        {
          "id": "PA450457",
          "name": "methylene blue",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452060842,
        "html": "<p>Avoid use</p>\n"
      },
      "implications": [
        "G6PD: High risk of acute hemolytic anemia"
      ],
      "lookupKey": {
        "G6PD": "Deficient"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": "36049896",
      "title": "Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.",
      "authors": [
        "Gammal Roseann S",
        "Pirmohamed Munir",
        "Somogyi Andrew A",
        "Morris Sarah A",
        "Formea Christine M",
        "Elchynski Amanda L",
        "Oshikoya Kazeem A",
        "McLeod Howard L",
        "Haidar Cyrine E",
        "Whirl-Carrillo Michelle",
        "Klein Teri E",
        "Caudle Kelly E",
        "Relling Mary V"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2022
    },
    {
      "pmid": "24787449",
      "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.",
      "authors": [
        "Relling M V",
        "McDonagh E M",
        "Chang T",
        "Caudle K E",
        "McLeod H L",
        "Haidar C E",
        "Klein T",
        "Luzzatto L",
        "Clinical Pharmacogenetics Implementation Consortium"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2014
    }
  ],
  "version": "2023-12-19-10-38"
}